go back

North Dakota rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $562,341 · 10th–90th $562,341–$1,000,0000%50%90th$562,341Professionalmedian $562,341 · 10th–90th $562,341–$707,9460%50%90th$562,341$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $1,000,000.00
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $707,945.78
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $660,693.45
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$831,763.77 / $831,763.77 / $831,763.77